Cardio Diagnostics
Get Started
Patients

Take The First Step Today Toward Better Heart Health

Cardio Diagnostics offers two prescription-only blood tests that patients can access via our telemedicine partner.

Epi+Gen CHD™

Epi+Gen CHD™ is a clinical test that assesses your three-year risk of experiencing a coronary heart disease event, such as a heart attack.

Epi+Gen CHD™ may be right for you if:

  • You are between 35 and 75 years old
  • You have not been diagnosed with coronary heart disease
  • You have not had a heart attack or any cardiac operation
  • You have not experienced angina (pain, heaviness, or discomfort in the chest, arm, jaw, or shoulder, especially with exertion)
  • You have not had a bone marrow transplant

Epi+Gen CHD™ is $350

PrecisionCHD™

PrecisionCHD™ is a clinical test that aids in the diagnosis and management of coronary heart disease, the most common type of heart disease and the primary cause of heart attacks.

PrecisionCHD™ may be right for you if:

  • You are between 35 and 80 years old
  • You have signs or symptoms indicative of coronary heart disease
  • You have not had a bone marrow transplant

PrecisionCHD™ is $850

The cost of the test may be reimbursed by your FSA/HSA, contact your individual FSA/HSA for more information.

Request a Test

Request a Test Via Telemedicine

1

Request a test and complete a brief health history questionnaire and a licensed provider will confirm your eligibility and prescribe the test.

2

If prescribed, we’ll ship an at-home kit directly to you so you can easily collect your sample at home and ship it to the lab.

3

Test results will be shared within 10 business days of sample receipt and you may schedule a consult with the provider to review your results.

Tests are not available for patients in New York.

Is Epi+Gen CHD™ or PrecisionCHD™ Right for You?

Complete a pretest questionnaire to see which Cardio Diagnostics test may be right for you.

This tool will ask you up to 5 questions about your age and health history. Based on your answers, we'll point you to the test that best fits your profile.

Cardio Diagnostics test collection kit

What Makes Our Tests Different

By combining epigenetics with AI, our tests go beyond traditional tests to measure your unique molecular biology.

Non-Invasive

Non-Invasive

Our blood tests do not require fasting or exposure to radiation that could increase cancer risk.

Advanced

Cutting-Edge

Our technology combines epigenetics, genetics, and AI to more comprehensively assess heart health even in the absence of risk factors.

Evidence-Based

Evidence-Based

Our tests are clinically validated, backed by peer-reviewed publications, and have high sensitivity and specificity.

Convenient

Accessible

Patients can request a test via our telemedicine partner and collect their sample at home. Once results are ready, the patient can complete a virtual consult with a provider to better understand what their results mean.

Frequently Asked Questions

Depending on where you are in your health journey, one test may be more appropriate for you than the other.

Epi+Gen CHD™ is a risk assessment test that identifies your likelihood of experiencing a coronary heart disease event, including a heart attack in the next three years. This test is intended for those who do not currently have signs or symptoms indicative of heart disease. Epi+Gen CHD™ is not intended for those who've had a heart attack or cardiac operation or experienced chest pain (especially with exertion) and those who have had a bone marrow transplant.

PrecisionCHD™ is a diagnostic test, meaning it's meant to help identify those who have coronary heart disease. If you have signs and symptoms indicative of heart disease or have been previously identified as being at high risk of developing heart disease, PrecisionCHD™ may be right for you. PrecisionCHD™ is not intended for those who have had a bone marrow transplant.

Ultimately, a licensed healthcare provider will determine if the test you requested is right for you based on all available information including your medical history, presence of risk factors and any signs or symptoms.
Epi+Gen CHD™ and PrecisionCHD™ both evaluate a panel of epigenetic and genetic biomarkers with artificial intelligence. Genetics accounts for your inherited risk of developing heart disease whereas epigenetics captures your acquired risk due to lifestyle and environmental factors. AI is able to interpret the patterns and complex interactions between your biomarkers. By integrating epigenetics, genetics, and AI, Cardio Diagnostics' tests assess your cardiovascular health unlike any other tool available today.
Epi+Gen CHD™ is $350 and PrecisionCHD™ is $850. Patients may be able to use FSA/HSA funds to pay for the tests.
Cardio Diagnostics' tests are prescription only. Patients can request a test via our telehealth partner here and a provider will determine if the test you requested is right for you.
Once a test is ordered by a provider, your sample collection kit will be shipped directly to your home and includes all the materials needed for collection and return of your blood sample. Inside, you’ll find finger lancets and a collection tube to obtain your blood sample, along with a return bag and a shipping label. After collecting your sample, place it in the return bag, attach the label, and drop off your package at any FedEx location.

Who We Serve

PatientsProvidersEmployers

Our Solutions

OverviewEpi+Gen CHD™PrecisionCHD™HeartRisk™CardioInnovate360™

Company

About UsAbout CVDCareersTechnologyResourcesNewsletterContact Us

Investors

Stock InformationSEC FilingsPress ReleasesPresentationsEmail SubscriptionCorporate GovernanceContact Investor Relations
Contact Us

2026 Cardio Diagnostics, Inc.

Privacy PolicyTerms of UseHIPAA Notice

The Cardio Diagnostics clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical laboratory testing. The Epi+Gen CHD™ and PrecisionCHD™ tests were developed, and their performance characteristics were determined by Cardio Diagnostics. These tests should be ordered by a licensed healthcare provider, and test results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms, and other relevant clinical information. These tests are intended for clinical purposes and have not been cleared or approved by the U.S. Food and Drug Administration (FDA).

For the Epi+Gen CHD™ test, a lower risk result does not eliminate the possibility of a coronary heart disease event occurring or that coronary heart disease is present, and a higher risk result does not imply a diagnosis of coronary heart disease or that a coronary heart disease event will occur. For the PrecisionCHD™ test, a "Signal Detected" result is not a diagnosis of coronary heart disease, and a "Signal Not Detected" result does not eliminate the possibility that coronary heart disease is present or could occur in the future. False positive and false negative test results do occur. Rx only.

In addition to a federal CLIA license, the Cardio Diagnostics clinical laboratory holds active state clinical laboratory licenses in California, Maryland, Pennsylvania, and Rhode Island. The laboratory is not currently licensed to process patient samples originating from the state of New York.